Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study.

IF 2.9 Q1 EMERGENCY MEDICINE
Archives of Academic Emergency Medicine Pub Date : 2024-06-22 eCollection Date: 2024-01-01 DOI:10.22037/aaem.v12i1.2327
Niloufar Taherpour, Koorosh Etemad, Yaser Mokhayeri, Saeid Fallah, Sahar Sotoodeh Ghorbani, Neda Izadi, Elham Rahimi, Fatemeh Shahbazi, Arash Seifi, Ahmad Mehri, Rezvan Feyzi, Kosar Farhadi-Babadi, Seyed Saeed Hashemi Nazari
{"title":"Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study.","authors":"Niloufar Taherpour, Koorosh Etemad, Yaser Mokhayeri, Saeid Fallah, Sahar Sotoodeh Ghorbani, Neda Izadi, Elham Rahimi, Fatemeh Shahbazi, Arash Seifi, Ahmad Mehri, Rezvan Feyzi, Kosar Farhadi-Babadi, Seyed Saeed Hashemi Nazari","doi":"10.22037/aaem.v12i1.2327","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Reinfection and hospital readmission due to COVID-19 were significant and costly during the pandemic. This study aimed to assess the rate and risk factors of SARS-Cov-2 reinfection, recurrence, and hospital readmission, by analyzing the national data registry in Iran.</p><p><strong>Methods: </strong>This study was a retrospective cohort conducted from March 2020 to May 2021. A census method was used to consider all of the possible information in the national Medical Care Monitoring Center (MCMC) database obtained from the Ministry of Health and Medical Education; the data included information from all confirmed COVID-19 patients who were hospitalized and diagnosed using at least one positive Polymerase Chain Reaction (PCR) test by nasopharyngeal swab specimens. Univariate and multivariable Cox regression analyses were performed to assess the factors related to each studied outcome.</p><p><strong>Results: </strong>After analyzing data from 1,445,441 patients who had been hospitalized due to COVID-19 in Iran, the rates of overall reinfection, reinfection occurring at least 90 days after the initial infection, recurrence, and hospital readmission among hospitalized patients were 67.79, 26.8, 41.61, and 30.53 per 1000 person-years, respectively. Among all cases of hospitalized reinfection (48292 cases), 38.61% occurred more than 90 days from the initial SARS-Cov-2 infection. Getting infected with COVID-19 in the fifth wave of the disease compared to getting infected in the first wave (P<0.001), having cancer (P<0.001), chronic kidney disease (P<0.001), and age over 80 years (P<0.001) were respectively the most important risk factors for overall reinfection. In contrast, age 19-44 years (P<0.001), intubation (P<0.001), fever (P<0.001), and cough (P<0.001) in the initial admission were the most important protective factors of overall reinfection, respectively.</p><p><strong>Conclusion: </strong>Reinfection and recurrence of COVID-19 after recovery and the rate of hospital readmission after discharge were remarkable. Advanced or young age, as well as having underlying conditions like cancer and chronic kidney disease, increase the risk of infection and readmission.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"12 1","pages":"e55"},"PeriodicalIF":2.9000,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11407538/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Academic Emergency Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/aaem.v12i1.2327","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Reinfection and hospital readmission due to COVID-19 were significant and costly during the pandemic. This study aimed to assess the rate and risk factors of SARS-Cov-2 reinfection, recurrence, and hospital readmission, by analyzing the national data registry in Iran.

Methods: This study was a retrospective cohort conducted from March 2020 to May 2021. A census method was used to consider all of the possible information in the national Medical Care Monitoring Center (MCMC) database obtained from the Ministry of Health and Medical Education; the data included information from all confirmed COVID-19 patients who were hospitalized and diagnosed using at least one positive Polymerase Chain Reaction (PCR) test by nasopharyngeal swab specimens. Univariate and multivariable Cox regression analyses were performed to assess the factors related to each studied outcome.

Results: After analyzing data from 1,445,441 patients who had been hospitalized due to COVID-19 in Iran, the rates of overall reinfection, reinfection occurring at least 90 days after the initial infection, recurrence, and hospital readmission among hospitalized patients were 67.79, 26.8, 41.61, and 30.53 per 1000 person-years, respectively. Among all cases of hospitalized reinfection (48292 cases), 38.61% occurred more than 90 days from the initial SARS-Cov-2 infection. Getting infected with COVID-19 in the fifth wave of the disease compared to getting infected in the first wave (P<0.001), having cancer (P<0.001), chronic kidney disease (P<0.001), and age over 80 years (P<0.001) were respectively the most important risk factors for overall reinfection. In contrast, age 19-44 years (P<0.001), intubation (P<0.001), fever (P<0.001), and cough (P<0.001) in the initial admission were the most important protective factors of overall reinfection, respectively.

Conclusion: Reinfection and recurrence of COVID-19 after recovery and the rate of hospital readmission after discharge were remarkable. Advanced or young age, as well as having underlying conditions like cancer and chronic kidney disease, increase the risk of infection and readmission.

SARS-Cov-2 住院病人再感染、复发和再次入院的比率和风险因素;一项全国队列研究。
导言:在疫情期间,COVID-19 导致的再感染和再入院现象十分严重,且代价高昂。本研究旨在通过分析伊朗的国家数据登记册,评估 SARS-Cov-2 再感染、复发和再入院的比率和风险因素:本研究是一项回顾性队列研究,时间为 2020 年 3 月至 2021 年 5 月。研究采用普查方法,考虑了从卫生和医学教育部获得的国家医疗监控中心(MCMC)数据库中所有可能的信息;数据包括所有确诊的 COVID-19 患者的信息,这些患者均住院治疗,并通过鼻咽拭子标本进行至少一次聚合酶链反应(PCR)阳性检测确诊。研究人员进行了单变量和多变量考克斯回归分析,以评估与各研究结果相关的因素:对伊朗 1,445,441 名因 COVID-19 而住院的患者的数据进行分析后发现,住院患者的总体再感染率、初次感染后至少 90 天的再感染率、复发率和再入院率分别为每千人年 67.79 例、26.8 例、41.61 例和 30.53 例。在所有住院再感染病例(48292 例)中,有 38.61% 的病例发生在首次感染 SARS-Cov-2 后 90 天以上。与在第一波感染相比,在第五波感染 COVID-19 (PConclusion:康复后再次感染和复发 COVID-19,以及出院后再次入院的比例都很高。高龄或年轻以及患有癌症和慢性肾病等基础疾病会增加感染和再次入院的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archives of Academic Emergency Medicine
Archives of Academic Emergency Medicine Medicine-Emergency Medicine
CiteScore
8.90
自引率
7.40%
发文量
0
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信